Belgium Medical Inc.-U.S. Distributor on Board
7/29/2004
Belgium Medical Inc.-U.S. Distributor on Board 2004-07-29 14:03 ET - News Release VANCOUVER, Britsih Columbia -- (Business Wire) -- July 29, 2004 Meridian Co. Ltd. ("Meridian" or the "Company") (OTCBB:MRDAF), is pleased to announce that its subsidiary, Meridian Medical Inc. ("MMI") has signed a contract with CardioGrade, based in Pleasanton, California to become its United States Distributor of the Digital Pulse Analyzer ("DPA"). Using information provided by a "pulse waveform", the DPA measures the elasticity of small and large arteries and provides information regarding arterial aging. The FDA approved device is inexpensive, non-invasive, and can provide results in one minute. The DPA can detect early signs of arterial wall dysfunction - a precursor of peripheral vascular disease, heart attacks and strokes. Such critical information can be used by the practitioner to determine if further investigation is required or to monitor effectiveness of treatment choices such as prescribed lifestyle changes (diet, exercise, smoking cessation etc.) and/or pharmaceuticals and nutraceuticals. Mark R. Rosales, President of CardioGrade, LLC has extensive sales and corporate experience predominately within the health care industry. While working as the Vice President of Sales and Business Development for United Therapeutics, (makers of HeartBar) he established a direct selling company with one product, taking the company from $40,000 in monthly sales to $400,000 per month in 9 months. During this time he also recruited 16,000 new members in 24 months in 3 countries and maintained 6,000 Active Distributors. Every prior sales and marketing venture Mr. Rosales has entered into has shown equally impressive results. Mr. Rosales also has relationships with several prominent physicians, endocrinologists and naturopaths throughout the United States who have expressed serious interest in the DPA. Mr. Rosales states, "The DPA is a quality product with an extremely competitive price, making it a highly marketable product in the United States." He further states, "I started CardioGrade to contribute to the wellness industry, particularly in regards to cardiovascular disease as it's the number one cause of death in the United States and contributes to a third of global deaths. I'm excited at the prospect of partnering with Meridian to see these statistics reduced. I can say without hesitation that this product will be remarkably successful, throughout the United States, but also in Mexico, South America and Europe." CardioGrade has projected a minimum sales goal of 50 DPA units per month through the next quarter. Based on these projections, Meridian will receive revenues of US$200,000 per month. Mr. Rosales has been collaborating with physicians conducting research on the effects of "L-Arginine", an amino acid that has been shown to reverse endothelial damage. The endothelium is the innermost thin tissue that lines blood vessels and the health of the endothelium directly affects overall cardiovascular health. "The DPA would compliment this type of research by providing a measuring device of efficacy," states Mr. Rosales. The DPA has a new software program that provides measurement of Heart Rate Variability (HRV). Low HRV has been shown in numerous longitudinal studies to be related to a higher mortality rate in both healthy and unhealthy subjects and thus can be shown to be a strong predicator of all-cause mortality. The heart is not just a simple pump but a complex sensory organ with its own functional "heart brain" that communicates with and influences the brain via the nervous system, hormonal system and other pathways. Research has shown that these influences profoundly affect brain function and most of the body's major organs. Science now confirms that stress significantly increases the risk of heart disease, including sudden cardiac death. Unmanaged emotional stress is equally if not more important than physical variables in determining health outcomes. A conservative estimate is that 75% of visits to primary care physicians are due to stress-related disorders. Cardiovascular related issues are not the only uses for the DPA. Psychologists are increasingly recognizing the importance of HRV. A number of studies have demonstrated that patients with anxiety, phobias and post-traumatic stress disorder (PSTD) consistently show lower HRV, even when not exposed to a trauma related prompt. Importantly, this relationship existed independent of age, gender, trait anxiety, cardio-respiratory fitness, heart rate, blood pressure and respiration rate. ABOUT MERIDIAN Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of it's products. Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity. Contacts: Meridian Co., Ltd. Debbie Williams President (604) 926-3495 Website (Korean): www.meridian.co.kr Website (North America): meridianmedical.ca
|